Journal of Surgery Concepts & Practice >
Advances in surgical treatment of hepatocellular carcinoma
HUANG Jiwei, QIU Guoteng, ZENG Yong . Advances in surgical treatment of hepatocellular carcinoma[J]. Journal of Surgery Concepts & Practice, 2022 , 27(02) : 113 -118 . DOI: 10.16139/j.1007-9610.2022.02.005
| [1] | Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: new trends[J]. J Hepatol, 2020, 72(2):250-261. |
| [2] | Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. |
| [3] | Njei B, Rotman Y, Ditah I, et al. Emerging trends in hepatocellular carcinoma incidence and mortality[J]. Hepatology, 2015, 61(1):191-199. |
| [4] | Vibert E, Schwartz M, Olthoff KM. Advances in resection and transplantation for hepatocellular carcinoma[J]. J He-patol, 2020, 72(2):262-276. |
| [5] | Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers, 2021, 7(1):6. |
| [6] | Labgaa I, Tabrizian P, Titano J, et al. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma[J]. HPB (Oxford), 2019, 21(11):1497-1504. |
| [7] | Gao Q, Anwar IJ, Abraham N, et al. Liver transplantation for hepatocellular carcinoma after downstaging or brid-ging therapy with immune checkpoint inhibitors[J]. Can-cers (Basel), 13(24):6307. |
| [8] | Prodeau M, Drumez E, Duhamel A, et al. An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy[J]. J He-patol, 2019, 71(5):920-929. |
| [9] | Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults[J]. Liver Transpl, 2002, 8(3):233-240. |
| [10] | Kawaguchi Y, Lillemoe HA, Vauthey JN. Surgical resection: old dog, any new tricks?[J]. Clin Liver Dis, 2020, 24(4):637-655. |
| [11] | Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma[J]. Br J Surg, 2006, 93(9):1091-1098. |
| [12] | Sandström P, Røsok BI, Sparrelid E, et al. ALPPS improves resectability compared with conventional two-stage hepatectomy in patients with advanced colorectal liver metastasis: results from a Scandinavian multicenter randomized controlled trial(LIGRO Trial)[J]. Ann Surg, 2018, 267(5):833-840. |
| [13] | 洪德飞, 彭淑牖, 刘允怡. ALPPS治疗肝细胞癌10年回望:永恒的理念慎选的术式[J]. 中华外科杂志, 2022, 60(2):113-116. |
| [14] | 国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版)[J]. 临床肝胆病杂志, 2022, 38(2):288-303. |
| [15] | Troisi RI, Berardi G, Morise Z, et al. Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study[J]. Br J Surg, 2021, 108(2):196-204. |
| [16] | Berardi G, Morise Z, Sposito C, et al. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis[J]. J Hepatol, 2020, 72(1):75-84. |
| [17] | Harimoto N, Yoshizumi T, Fujimoto Y, et al. Surgery for hepatocellular carcinoma in patients with Child-Pugh B cirrhosis: hepatic resection versus living donor liver transplantation[J]. World J Surg, 2018, 42(8):2606-2616. |
| [18] | Kawaguchi Y, Hasegawa K, Tzeng CD, et al. Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity[J]. Br J Surg, 2020, 107(3):258-267. |
| [19] | Reich H, McGlynn F, DeCaprio J, et al. Laparoscopic excision of benign liver lesions[J]. Obstet Gynecol, 1991, 78(5 Pt 2):956-568. |
| [20] | 周伟平, 孙志宏, 吴孟超, 等. 经腹腔镜肝叶切除首例报道[J]. 肝胆外科杂志, 1994, 2(2):82. |
| [21] | Yoon YI, Kim KH, Kang SH, et al. Pure laparoscopic versus open right hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score matched analysis[J]. Ann Surg, 2017, 265(5):856-863. |
| [22] | Schmelzle M, Krenzien F, Schöning W, et al. Laparosco-pic liver resection: indications, limitations, and economic aspects[J]. Langenbecks Arch Surg, 2020, 405(6):725-735. |
| [23] | Xiangfei M, Yinzhe X, Yingwei P, et al. Open versus laparoscopic hepatic resection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Surg Endosc, 2019, 33(8):2396-2418. |
| [24] | Cucchetti A, Qiao GL, Cescon M, et al. Anatomic versus nonanatomic resection in cirrhotic patients with early hepatocellular carcinoma[J]. Surgery, 2014, 155(3):512-521. |
| [25] | Jiao S, Li G, Zhang D, et al. Anatomic versus nona-natomic resection for hepatocellular carcinoma, do we have an answer? a meta-analysis[J]. Int J Surg, 2020, 80:243-255. |
| [26] | Kobayashi Y, Kawaguchi Y, Kobayashi K, et al. Portal vein territory identification using indocyanine green fluorescence imaging: technical details and short-term outcomes[J]. J Surg Oncol, 2017, 116(7):921-931. |
| [27] | Satou S, Ishizawa T, Masuda K, et al. Indocyanine green fluorescent imaging for detecting extrahepatic metastasis of hepatocellular carcinoma[J]. J Gastroenterol, 2013, 48(10):1136-1143. |
| [28] | He P, Huang T, Fang C, et al. Identification of extrahepatic metastasis of hepatocellular carcinoma using indocyanine green fluorescence imaging[J]. Photodiagnosis Photodyn Ther, 2019, 25:417-420. |
| [29] | Li WF, Al-Taher M, Yu CY, et al. Super-selective intra-arterial indocyanine green administration for near-infrared fluorescence-based positive staining of hepatic segmentation: a feasibility study[J]. Surg Innov, 2021, 28(6):669-678. |
| [30] | Ueno M, Hayami S, Sonomura T, et al. Indocyanine green fluorescence imaging techniques and interventional radiology during laparoscopic anatomical liver resection (with video)[J]. Surg Endosc, 2018, 32(2):1051-1055. |
| [31] | Di Benedetto F, Petrowsky H, Magistri P, et al. Robotic liver resection: hurdles and beyond[J]. Int J Surg, 2020, 82S:155-162. |
| [32] | Hu M, Liu Y, Li C, et al. Robotic versus laparoscopic liver resection in complex cases of left lateral sectionectomy[J]. Int J Surg, 2019, 67:54-60. |
| [33] | Villanueva A. Hepatocellular Carcinoma[J]. N Engl J Med, 2019, 380(15):1450-1462. |
| [34] | Zheng K, Zhu X, Fu S, et al. Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib for hepatocellular carcinoma with major portal vein tumor thrombosis: a randomized trial[J]. Radiology, 2022, 303(2):455-464. |
| [35] | Ding X, Sun W, Li W, et al. Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: a prospective randomized study[J]. Cancer, 2021, 127(20):3782-3793. |
| [36] | Hamaoka M, Kobayashi T, Kuroda S, et al. Hepatectomy after down-staging of hepatocellular carcinoma with portal vein tumor thrombus using chemoradiotherapy: a retrospective cohort study[J]. Int J Surg, 2017, 44:223-228. |
| [37] | Lau WY, Lai EC. Salvage surgery following downstaging of unresectable hepatocellular carcinoma—a strategy to increase resectability[J]. Ann Surg Oncol, 2007, 14(12):3301-3309. |
| [38] | Kokudo T, Hasegawa K, Matsuyama Y, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion[J]. J Hepatol, 2016, 65(5):938-943. |
| [39] | Zhang XP, Gao YZ, Chen ZH, et al. An eastern hepatobiliary surgery hospital/portal vein tumor thrombus sco-ring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study[J]. Hepatology, 2019, 69(5):2076-2090. |
| [40] | Wei X, Jiang Y, Zhang X, et al. Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study[J]. J Clin Oncol, 2019, 37(24):2141-2151. |
| [41] | Liou H, Mody K, Boyle AW, et al. Neoadjuvant radiation lobectomy and immunotherapy for angioinvasive HCC resulting in complete pathologic response[J]. Hepatology, 2021, 74(1):525-527. |
| [42] | Liu S, Guo L, Li H, et al. Postoperative adjuvant trans-arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus[J]. Ann Surg Oncol, 2018, 25(7):2098-2104. |
| [43] | Liang L, Li C, Diao YK, et al. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. Therap Adv Gastroenterol, 2020, 13:1756284820977693. |
| [44] | Sun J, Yang L, Shi J, et al. Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: an open-label randomized controlled trial[J]. Radiother Oncol, 2019, 140:20-25. |
| [45] | Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 1996, 334(11):693-699. |
| [46] | Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival[J]. Hepatology, 2001, 33(6):1394-1403. |
| [47] | Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan Criteria: a retrospective, exploratory analysis[J]. Lancet Oncol, 2009, 10(1):35-43. |
| [48] | Kwong A, Mehta N. Expanding the limits of liver transplantation for hepatocellular carcinoma: is there a limit?[J]. Clin Liver Dis, 2021, 25(1):19-33. |
| [49] | Hameed B, Mehta N, Sapisochin G, et al. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carci-noma meeting the Milan Criteria[J]. Liver Transpl, 2014, 20(8):945-951. |
| [50] | Mehta N, Dodge JL, Grab JD, et al. National experience on down-staging of hepatocellular carcinoma before liver transplant: influence of tumor burden, alpha-fetoprotein, and wait time[J]. Hepatology, 2020, 71(3):943-954. |
| [51] | Fernandez-Sevilla E, Allard MA, Selten J, et al. Recurrence of hepatocellular carcinoma after liver transplantation: is there a place for resection?[J]. Liver Transpl, 2017, 23(4):440-447. |
| [52] | de′Angelis N, Landi F, Carra MC, et al. Managements of recurrent hepatocellular carcinoma after liver transplantation: a systematic review[J]. World J Gastroenterol, 2015, 21(39):11185-11198. |
| [53] | Halazun KJ, Najjar M, Abdelmessih RM, et al. Recurrence after liver transplantation for hepatocellular carcinoma: a new MORAL to the story[J]. Ann Surg, 2017, 265(3):557-564. |
/
| 〈 |
|
〉 |
